-
Signature
-
/s/ Lana B. Persaud, Attorney-in-Fact
-
Stock symbol
-
COUR
-
Transactions as of
-
Jul 28, 2023
-
Transactions value $
-
-$543,130
-
Form type
-
4
-
Date filed
-
8/1/2023, 04:56 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
COUR |
Common Stock |
Options Exercise |
$66.5K |
+29.8K |
+3.13% |
$2.23* |
983K |
Jul 28, 2023 |
Direct |
|
transaction |
COUR |
Common Stock |
Sale |
-$393K |
-27.3K |
-2.78% |
$14.38 |
956K |
Jul 28, 2023 |
Direct |
F1, F2 |
transaction |
COUR |
Common Stock |
Sale |
-$38K |
-2.5K |
-0.26% |
$15.20 |
953K |
Jul 28, 2023 |
Direct |
F1 |
transaction |
COUR |
Common Stock |
Options Exercise |
$29.7K |
+13.3K |
+1.4% |
$2.23* |
967K |
Jul 31, 2023 |
Direct |
|
transaction |
COUR |
Common Stock |
Sale |
-$208K |
-13.3K |
-1.38% |
$15.62 |
953K |
Jul 31, 2023 |
Direct |
F1, F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
COUR |
Stock Option (right to buy) |
Options Exercise |
$0 |
-29.8K |
-8.46% |
$0.00 |
323K |
Jul 28, 2023 |
Common Stock |
29.8K |
$2.23 |
Direct |
F4 |
transaction |
COUR |
Stock Option (right to buy) |
Options Exercise |
$0 |
-13.3K |
-4.13% |
$0.00 |
310K |
Jul 31, 2023 |
Common Stock |
13.3K |
$2.23 |
Direct |
F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: